[
  {
    "ts": null,
    "headline": "Here's Why ResMed (RMD) is a Strong Value Stock",
    "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",
    "url": "https://finnhub.io/api/news?id=e9e2a284e3f32488a0ae3c5236271ddd5170d159037ae647dd0278394113e060",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735569612,
      "headline": "Here's Why ResMed (RMD) is a Strong Value Stock",
      "id": 132204152,
      "image": "",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",
      "url": "https://finnhub.io/api/news?id=e9e2a284e3f32488a0ae3c5236271ddd5170d159037ae647dd0278394113e060"
    }
  },
  {
    "ts": null,
    "headline": "Reasons to Retain AMED Stock in Your Portfolio Now",
    "summary": "Amedisys' expected merger with UnitedHealth Group's Optum brings optimism to investors. Yet, a dull macroeconomic condition adds to the worry.",
    "url": "https://finnhub.io/api/news?id=0e5c425d9e12af98342787bf0cc8ecc5d2ce7ad88e56c27e786b43b51c9d108a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735561020,
      "headline": "Reasons to Retain AMED Stock in Your Portfolio Now",
      "id": 132202942,
      "image": "https://media.zenfs.com/en/zacks.com/9c7450ec9df154559fbeb393640d6629",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Amedisys' expected merger with UnitedHealth Group's Optum brings optimism to investors. Yet, a dull macroeconomic condition adds to the worry.",
      "url": "https://finnhub.io/api/news?id=0e5c425d9e12af98342787bf0cc8ecc5d2ce7ad88e56c27e786b43b51c9d108a"
    }
  },
  {
    "ts": null,
    "headline": "Investing in ResMed (NYSE:RMD) five years ago would have delivered you a 56% gain",
    "summary": "When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Furthermore...",
    "url": "https://finnhub.io/api/news?id=b6154111642b233b61eaf46788be508a3c97744eee324689fd196f90c0aece2d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735560017,
      "headline": "Investing in ResMed (NYSE:RMD) five years ago would have delivered you a 56% gain",
      "id": 132204154,
      "image": "",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Furthermore...",
      "url": "https://finnhub.io/api/news?id=b6154111642b233b61eaf46788be508a3c97744eee324689fd196f90c0aece2d"
    }
  },
  {
    "ts": null,
    "headline": "Nyxoah: The Future Of OSA",
    "summary": "Nyxoah's disrupting Genio implant is likely to revolutionize Obstructive Sleep Apnea, and FDA's decision is expected in Q1 '25. Read why NYXH stock is a Buy.",
    "url": "https://finnhub.io/api/news?id=84a71249dd0929076d14124a4d02982a364422f6ff29b7ea00c874262d5590ec",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735531301,
      "headline": "Nyxoah: The Future Of OSA",
      "id": 132200797,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1222911599/image_1222911599.jpg?io=getty-c-w1536",
      "related": "RMD",
      "source": "SeekingAlpha",
      "summary": "Nyxoah's disrupting Genio implant is likely to revolutionize Obstructive Sleep Apnea, and FDA's decision is expected in Q1 '25. Read why NYXH stock is a Buy.",
      "url": "https://finnhub.io/api/news?id=84a71249dd0929076d14124a4d02982a364422f6ff29b7ea00c874262d5590ec"
    }
  }
]